Examples of using Pneumococcal in English and their translations into Hungarian
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Programming
-
Official/political
-
Computer
In adults vaccinated with pneumococcal polysaccharide vaccine at least 5 years prior to the clinical study, OPA GMTs to Prevenar 13 were non-inferior to the 23-valent pneumococcal polysaccharide vaccine responses for the 12 serotypes in common.
Individuals considered to be at a higher risk of pneumococcal infection(such as those with sickle cell disease or HIV infection), including those previously vaccinated with the 23-valent pneumococcal polysaccharide vaccine, may receive at least one dose of Prevenar 13.
Individuals who have underlying conditions predisposing them to invasive pneumococcal disease(such as sickle cell disease or HIV infection) including those previously vaccinated with one or more doses of 23-valent pneumococcal polysaccharide vaccine may receive at least one dose of Prevenar 13(see section 5.1).
Because so few people at risk have received the vaccine, the CDC is not now recommending the pneumococcal vaccine for healthy adults-- even though some of the severe cases reported to the CDC have been in people without pneumococcal risk factors.
Pneumococcal polysaccharide serotype 4* 2 micrograms Pneumococcal polysaccharide serotype 6B* 4 micrograms Pneumococcal polysaccharide serotype 9V* 2 micrograms Pneumococcal polysaccharide serotype 14* 2 micrograms Pneumococcal polysaccharide serotype 18C* 2 micrograms Pneumococcal polysaccharide serotype 19F* 2 micrograms Pneumococcal polysaccharide serotype 23F* 2 micrograms.
hepatitis B, pneumococcal conjugate vaccine
298 children aged 10 to 17 years who had not received a pneumococcal vaccine).
Based on surveillance data following the introduction of Prevenar but before the introduction of Prevenar 13 in childhood vaccination programmes, the pneumococcal serotypes in Prevenar 13 may be responsible for at least 50- 76%(depending on country) of IPD in adults.
heptavalent pneumococcal conjugate, measles,
Immune responses to Prevenar 13 and 23-valent pneumococcal polysaccharide vaccine were compared in a head to head trial in adults aged≥ 70 years, who had received a single dose of pneumococcal polysaccharide vaccine at least 5 years before study vaccination.
adult RA patients treated with RoActemra and MTX were able to mount an effective response to both the 23-valent pneumococcal polysaccharide and tetanus toxoid vaccines which was comparable to the response seen in patients on MTX only.
dose of Prevenar 13, the OPA titers to serotype 6A were significantly greater than in adults≥ 60 years who received a single dose of 23-valent pneumococcal polysaccharide vaccine.
In clinical studies when Prevenar 13 was given 1 year after 23-valent pneumococcal polysaccharide vaccine the immune responses were lower for all serotypes compared to when Prevenar 13 was given to subjects not previously immunised with 23-valent pneumococcal polysaccharide vaccine.
Inconsistent results were seen across studies for responses to inactivated poliovirus type 2 and pneumococcal conjugate serotype 6B
Safety and immunogenicity data are not yet available for children in other specific high-risk groups for invasive pneumococcal disease(e.g. children with another congenital
Inconsistent results were seen across studies for responses to inactivated poliovirus type 2 and pneumococcal conjugate serotype 6B
The effectiveness(both direct and indirect effect) of 7-valent Prevenar against pneumococcal disease has been evaluated in both three-dose
The use of Synflorix should be determined on the basis of official recommendations taking into consideration the impact on pneumococcal diseases in different age groups as well as the variability of the epidemiology in different geographical areas.
When Infanrix hexa is co-administered with Prevenar(pneumococcal saccharide conjugated vaccine,
Data on concomitant administration of Infanrix hexa with Prevenar(pneumococcal saccharide conjugated vaccine,